Pyrimidinyl aryl urea derivatives being FGF inhibitors
US8293746B2 · kind B2 · utility
12Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2006 |
| Grant date | Oct 23, 2012 |
| Priority date | — |
| Expiry date | Aug 6, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to heteroaryl aryl ureas of the formula IA,wherein the radicals and symbols have the meanings as defined herein, the use of such compounds in the treatment of protein kinase dependent diseases; to pharmaceutical preparations comprising said heteroaryl aryl ureas, to processes for the manufacture of such novel compounds and to methods of treatment comprising the use of such heteroaryl aryl ureas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.